Correspondence on Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis "

被引:0
作者
Cheung, Ka Shing [1 ,2 ]
Mok, Chiu Hang [3 ]
Seto, Wai Kay [1 ,2 ,4 ,5 ]
Yuen, Man Fung [1 ,4 ,5 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Sch Clin Med, Dept Med, Hong Kong, Peoples R China
[2] Univ Hong Kong, Shenzhen Hosp, Dept Med, Shenzhen, Peoples R China
[3] Univ Hong Kong, Sch Clin Med, Hong Kong, Peoples R China
[4] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China
[5] Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam Rd, Hong Kong, Peoples R China
关键词
COVID-19; Vaccination; Non-alcoholic fatty liver disease; Fatty liver; ASSOCIATION;
D O I
10.3350/cmh.2022.0377
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:176 / 178
页数:4
相关论文
共 11 条
[1]   COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis [J].
Cheung, Ka Shing ;
Mok, Chiu Hang ;
Mao, Xianhua ;
Zhang, Ruiqi ;
Hung, Ivan F. N. ;
Seto, Wai Kay ;
Yuen, Man Fung .
CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (04) :890-911
[2]   Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients [J].
Cheung, Ka Shing ;
Lam, Lok Ka ;
Hui, Rex Wan Hin ;
Mao, Xianhua ;
Zhang, Ruiqi R. ;
Chan, Kwok Hung ;
Hung, Ivan F. N. ;
Seto, Wai Kay ;
Yuen, Man-Fung .
CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (03) :553-564
[3]   Association Between Famotidine Use and COVID-19 Severity in Hong Kong: A Territory-wide Study [J].
Cheung, Ka Shing ;
Hung, Ivan F. N. ;
Leung, Wai K. .
GASTROENTEROLOGY, 2021, 160 (05) :1898-1899
[4]   Association between angiotensin blockade and COVID-19 severity in Hong Kong [J].
Cheung, Ka Shing ;
Hung, Ivan F. N. ;
Leung, Wai K. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (23) :E635-E635
[5]   Association between Recent Usage of Antibiotics and Immunogenicity within Six Months after COVID-19 Vaccination [J].
Cheung, Ka-Shing ;
Lam, Lok-Ka ;
Zhang, Ruiqi ;
Ooi, Poh-Hwa ;
Tan, Jing-Tong ;
To, Wai-Pan ;
Hui, Chun-Him ;
Chan, Kwok-Hung ;
Seto, Wai-Kay ;
Hung, Ivan F. N. ;
Leung, Wai K. .
VACCINES, 2022, 10 (07)
[6]   Forms of cholangitis to be considered after SARS-CoV-2 infection [J].
Cho, Ju-Yeon ;
Lee, Young-Sun ;
Kim, Soon Sun ;
Song, Do Seon ;
Lee, Jeong-Hoon ;
Kim, Ji Hoon .
CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (04) :929-930
[7]   Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline [J].
Cho, Ju-Yeon ;
Lee, Young-Sun ;
Kim, Soon Sun ;
Song, Do Seon ;
Lee, Jeong-Hoon ;
Kim, Ji Hoon .
CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (04) :515-523
[8]   Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study [J].
Lee, Soon Kyu ;
Kwon, Jung Hyun ;
Yoon, Nara ;
Nam, Soon Woo ;
Sung, Pil Soo .
CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (04) :926-928
[9]   Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis A Systematic Review and Meta-analysis [J].
Ma, Qiuyue ;
Liu, Jue ;
Liu, Qiao ;
Kang, Liangyu ;
Liu, Runqing ;
Jing, Wenzhan ;
Wu, Yu ;
Liu, Min .
JAMA NETWORK OPEN, 2021, 4 (12) :e2137257
[10]   Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis" [J].
Mungmunpuntipantip, Rujittika ;
Wiwanitkit, Viroj .
CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01)